Cover Image

PREVALENCE OF EXTRAPYRAMIDAL SYMPTOMS AMONG INSTITUTIONALISED CHRONIC PSYCHOTIC PATIENTS

ARCHANA .

Abstract


OBJECTIVE 1. To study prevalence of    Extrapyramidal symptoms (EPS) among institutionalized chronic      psychotic patients.2. To study the various factors associated with presence of EPS.METHODOLOGY A total of 382 male and female patients hospitalized with psychotic symptoms and treated with neuroleptics were screened for evidence of EPS clinically.RESULTS A total of 42 patients, 24 males and 18 females, developed EPS within few days of initiation of neuroleptics. They were on both typical and           atypical  antipsychotics.CONCLUSION Prevalence of EPS was 11 all the patients were suffering from Schizophrenia and treated with oral neuroleptics.

 


Full Text:

PDF

References


Andrew,;atypicality of atypical antipsychotics. Prim care companion J clin psychiatry 2005 ;7:268-274.

Dolder CR; Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry 2003; 53: 1142–5.

Kane JM; tardive dyskinesia-prevalence, incidence and risk factors. J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):52S-56S. Review

Marder SR; Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151: 825–35.

Miller et al; extrapyramidal side effects of antipsychotics in a randomized trial. The British Journal of Psychiatry (2008) 193, 279–288.

Rajeev Kumar;Perminder S. Sachdev, Akathisia and Second-generation Antipsychotic Drugs. Curr Opin Psychiatry. 2009;22(3):293-299.

Seeman P;atypical antipsychotics : mechanism of action. Can J psychiatry 2002;47:27-38


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University